Health
Has The Market Overpriced Moderna’s Vaccine? – Forbes
Moderna stock has jumped by about 4x this year adding over $20 billion in market value, as investors bet that a successful Covid-19 vaccine could generate windfall profits for the clinical-stage biotech company. Is this jump in valuation warranted? We don’t t…
Medical syringe is seen with Moderna company logo displayed on a screen in the background in this ……
Continue Reading
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General15 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News24 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia